中国生物医学再生科技有限公司.PDFVIP

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no resp onsibility f or the contents of this announcement, make no rep resentation as to its accuracy or comp leteness and exp ressly disclaim any liability whatsoever f or any loss howsoever arising f rom or in reliance up on the whole or any p art of the contents of this announcement. China Bio-Med Regeneration Technology Limited (Incorp orated in the Cayman Islands with limited liability) (Stock Code: 8158) DISCLOSEABLE TRANSACTION PLACING OF INVESTMENT IN LISTED COMPANIES The Board announces that Asia First, a wholly-owned subsidiary of the Company and the Placing Agent entered into the Placing Agreement on 31 March 2009 pursuant to which the Placing Agent has agreed to act as placing agent for the purpose of a private placing of the Portfolio comprising of listed shares and non-listed warrants of a listed company at a cash consideration of HK$17,000,000. As the applicable percentage ratios for the Placing are more than 5% but less than 25%, the Placing constitute a discloseable transaction on the part of the Company pursuant to Rule 19.06(2) of the GEM Listing Rules. PLACING AGREEMENT The Board announces that Asia First, a wholly-owned subsidiary of the Company, and the Placing Agent entered into the Placing Agreement on 31 March 2009 pursuant to which the Placing Agent has agreed to act as placing agent for the purpose of a private placing of the Portfolio comprising of listed shares and non-listed warrants of a listed company in Hong Kong at a cash consideration of HK$17,000,000. PLACING AGENT To the